ロボット生検装置市場：製品タイプ、用途別-2025-2030年の世界予測

ロボット生検装置市場は、2023年に4億1,631万米ドルと評価され、2024年には4億5,870万米ドルに達すると予測され、CAGR 11.16%で成長し、2030年には8億7,322万米ドルに達すると予測されています。

ロボット生検装置市場には、診断分析のための組織サンプルの正確な抽出を支援するように設計された先進ロボットシステムの開拓、生産、応用が含まれます。ロボット生検装置の必要性は、生検による定期的なモニタリングを必要とするがんやその他の疾患の罹患率の増加とともに、患者の不快感や回復時間を軽減する低侵襲処置への需要の高まりに後押しされています。これらの治療機器は主に病院や診断センターなどのヘルスケア環境で使用され、病理医や腫瘍医などの医療専門家が診断や治療計画の正確性を追求しています。

市場成長は、ロボット技術やイメージング技術の技術進歩、高齢者人口の増加、ヘルスケア支出の増加の影響を大きく受けています。ターゲティング強化のための生検装置へのAI統合、組織抽出の自動化、リアルタイム分析などのイノベーションが潜在的な機会を生み出しています。神経疾患や心疾患の検出におけるロボット生検装置の用途拡大は、潜在的な市場をさらに広げています。しかし、ロボットシステムの高価格、熟練した専門家の必要性、規制上の課題、発展途上地域での限定的な採用といった障壁が大きな課題となっています。

新たなビジネスチャンスを生かすために、企業は診断精度を向上させるためのAI主導のデータ分析、より幅広い採用のための費用対効果の高いソリューションの開発、アクセシビリティ向上のためのユーザーインターフェースの強化といった分野に注力すべきです。ヘルスケア機関との共同研究に投資することで、ロボット支援技術のブレークスルーにつながる可能性があります。限界はあるもの、市場の性質は依然としてダイナミックであり、個別化医療の動向は精密診断ツールの必要性を強調しています。企業は、ロボット生検手技の効率を高め、手技全体のコストを削減するイノベーションを優先させるべきであり、競争が激化する中で幅広い市場への参入と持続的な成長を確保する必要があります。

市場力学：急速に進化するロボット生検装置市場の主要市場インサイトを公開

ロボット生検装置市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界のがん罹患率の上昇
  • 疾病診断用ロボットシステムの普及拡大
  • 低侵襲技術への嗜好による潜在的需要
• 市場抑制要因
  • 高額な投資と高価な装置
• 市場機会
  • 政府および民間機関によるヘルスケア支出の増加
  • 新興市場での潜在的成長
• 市場の課題
  • 熟練した専門家の不足

ポーターのファイブフォースロボット生検装置市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ロボット生検装置市場における外部からの影響の把握

外部マクロ環境要因は、ロボット生検装置市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ロボット生検装置市場における競合情勢の把握

ロボット生検装置市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスロボット生検装置市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ロボット生検装置市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ロボット生検装置市場における成功への道筋を描く

ロボット生検装置市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中でがんの発生が増加
    • 病気の診断のためのロボットシステムの普及が進む
    • 低侵襲技術への傾向による潜在的需要
  • 抑制要因
    • 投資コストが高く、デバイスも高価
  • 機会
    • 政府と民間機関によるヘルスケア費支出の増加
    • 新興市場における潜在的成長
  • 課題
    • 熟練した専門家の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ロボット生検装置市場：製品タイプ別

• 楽器とアクセサリー
• システム

第7章 ロボット生検装置市場：用途別

• 脳生検
• 肺生検
• 前立腺生検

第8章 南北アメリカのロボット生検装置市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のロボット生検装置市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのロボット生検装置市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Accuray Incorporated
• Becton, Dickinson and Company
• Biobot Surgical Pte Ltd.
• Eigen Health
• Hitachi Medical Systems
• Hologic, Inc.
• Intuitive Surgical, Inc.
• iSYS Medizintechnik GmbH
• Johnson & Johnson Services, Inc.
• Leica Biosystems
• Medrobotics Corporation
• Medtronic PLC
• Renishaw PLC
• Siemens Healthineers AG
• Stryker Corporation

LIST OF FIGURES

• FIGURE 1. ROBOTIC BIOPSY DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. ROBOTIC BIOPSY DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ROBOTIC BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. ROBOTIC BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ROBOTIC BIOPSY DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ROBOTIC BIOPSY DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY INSTRUMENT & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY BRAIN BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LUNG BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROSTATE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 22. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. CHINA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CHINA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. INDIA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. INDIA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. ITALY ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 71. ITALY ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. POLAND ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. POLAND ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. QATAR ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. QATAR ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ROBOTIC BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. ROBOTIC BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Robotic Biopsy Devices Market was valued at USD 416.31 million in 2023, expected to reach USD 458.70 million in 2024, and is projected to grow at a CAGR of 11.16%, to USD 873.22 million by 2030.

The scope of the robotic biopsy devices market involves the development, production, and application of advanced robotic systems designed to assist in the precise extraction of tissue samples for diagnostic analysis, particularly where traditional biopsy methods may be invasive or pose difficulties. The necessity of robotic biopsy devices is driven by the increasing demand for minimally invasive procedures that reduce patient discomfort and recovery time, alongside the growing incidence of cancer and other diseases requiring regular monitoring through biopsy. These devices are primarily used in healthcare settings, such as hospitals and diagnostic centers, with end-users including pathologists, oncologists, and other healthcare professionals aiming for accuracy in diagnosis and treatment planning.

Market growth is significantly influenced by technological advancements in robotics and imaging technologies, increasing elderly population, and rising healthcare expenditure. Innovations such as AI integration in biopsy devices for enhanced targeting, automation in tissue extraction, and real-time analytics are creating potential opportunities. The expanding applications of robotic biopsy devices in detecting neurological and cardiac diseases further broaden the potential market. However, barriers such as high costs of robotic systems, the need for skilled professionals, regulatory challenges, and limited adoption in developing regions pose significant challenges.

To capitalize on emerging opportunities, businesses should focus on areas like AI-driven data analytics to improve diagnostic accuracy, developing cost-effective solutions for wider adoption, and enhancing user interface for improved accessibility. Investing in research collaborations with healthcare institutions can lead to breakthroughs in robotic-assisted technologies. Despite limitations, the nature of the market remains dynamic, with a trend towards personalized medicine emphasizing the need for precision diagnostic tools. Companies should prioritize innovations that enhance the efficiency of robotic biopsy procedures and reduce overall procedural costs, ensuring broad market reach and sustained growth in an increasingly competitive landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Robotic Biopsy Devices Market

The Robotic Biopsy Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising occurrence of cancer worldwide
  • Increasing penetration of robotic systems for disease diagnosis
  • Potential demand due to penchant for minimally invasive techniques
• Market Restraints
  • High cost of investment and expensive devices
• Market Opportunities
  • Growing healthcare spending by governments and private institutes
  • Potential growth in emerging markets
• Market Challenges
  • Dearth of availability of skilled professional

Porter's Five Forces: A Strategic Tool for Navigating the Robotic Biopsy Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Robotic Biopsy Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Robotic Biopsy Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Robotic Biopsy Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Robotic Biopsy Devices Market

A detailed market share analysis in the Robotic Biopsy Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Robotic Biopsy Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Robotic Biopsy Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Robotic Biopsy Devices Market

A strategic analysis of the Robotic Biopsy Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Robotic Biopsy Devices Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Becton, Dickinson and Company, Biobot Surgical Pte Ltd., Eigen Health, Hitachi Medical Systems, Hologic, Inc., Intuitive Surgical, Inc., iSYS Medizintechnik GmbH, Johnson & Johnson Services, Inc., Leica Biosystems, Medrobotics Corporation, Medtronic PLC, Renishaw PLC, Siemens Healthineers AG, and Stryker Corporation.

Market Segmentation & Coverage

This research report categorizes the Robotic Biopsy Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Instrument & Accessories and System.
• Based on Application, market is studied across Brain Biopsy, Lung Biopsy, and Prostate Biopsy.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising occurrence of cancer worldwide
    • 5.1.1.2. Increasing penetration of robotic systems for disease diagnosis
    • 5.1.1.3. Potential demand due to penchant for minimally invasive techniques
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of investment and expensive devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing healthcare spending by governments and private institutes
    • 5.1.3.2. Potential growth in emerging markets
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of availability of skilled professional
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Robotic Biopsy Devices Market, by Product Type

• 6.1. Introduction
• 6.2. Instrument & Accessories
• 6.3. System

7. Robotic Biopsy Devices Market, by Application

• 7.1. Introduction
• 7.2. Brain Biopsy
• 7.3. Lung Biopsy
• 7.4. Prostate Biopsy

8. Americas Robotic Biopsy Devices Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Robotic Biopsy Devices Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Robotic Biopsy Devices Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Accuray Incorporated
• 2. Becton, Dickinson and Company
• 3. Biobot Surgical Pte Ltd.
• 4. Eigen Health
• 5. Hitachi Medical Systems
• 6. Hologic, Inc.
• 7. Intuitive Surgical, Inc.
• 8. iSYS Medizintechnik GmbH
• 9. Johnson & Johnson Services, Inc.
• 10. Leica Biosystems
• 11. Medrobotics Corporation
• 12. Medtronic PLC
• 13. Renishaw PLC
• 14. Siemens Healthineers AG
• 15. Stryker Corporation